Drug Search Results
More Filters [+]

Piritramide

Alternative Names: piritramide, piritramid
Latest Update: 2023-12-07
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: OPR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | Czech | Germany | Ireland | Luxembourg | Netherlands | Slovenia

Approved Indications: None

Known Adverse Events: None

Company: UZ Brussel
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Piritramide

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Abdominal Pain|Pain, Postoperative

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2020-003682-19

P3

Active, not recruiting

Pain, Postoperative|Abdominal Pain

2021-12-16

Recent News Events